Ligand validation:3P4W

PLC: DIUNDECYL PHOSPHATIDYL CHOLINE

PLC is a Ligand Of Interest in 3P4W designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3P4W_PLC_A_320	2%	13%	0.419	0.701	1.43	2.49	5	14	0	0	79%	0.7857
3P4W_PLC_B_321	1%	67%	0.471	0.836	0.62	0.64	-	-	0	0	21%	0.2143
3P4W_PLC_E_320	1%	12%	0.446	0.686	1.54	2.51	6	14	0	0	79%	0.7857
3P4W_PLC_C_321	1%	13%	0.448	0.685	1.49	2.45	6	12	0	0	79%	0.7857
3P4W_PLC_A_321	1%	60%	0.493	0.823	0.82	0.7	-	-	0	0	21%	0.2143
3P4W_PLC_C_322	1%	69%	0.564	0.896	0.53	0.65	-	-	0	0	21%	0.2143
3P4W_PLC_D_320	1%	12%	0.457	0.681	1.52	2.54	5	13	0	0	79%	0.7857
3P4W_PLC_B_320	1%	13%	0.448	0.668	1.49	2.48	6	12	0	0	79%	0.7857
3P4W_PLC_E_321	1%	68%	0.546	0.871	0.6	0.62	-	-	0	0	21%	0.2143
3P4W_PLC_D_321	1%	62%	0.509	0.818	0.73	0.71	-	-	0	0	21%	0.2143
3UUB_PLC_F_320	16%	88%	0.19	0.908	0.45	0.22	-	-	0	0	17%	16.669999999999998
6HZ1_PLC_E_401	12%	95%	0.233	0.842	0.19	0.2	-	-	0	0	57%	0.5714
4QH5_PLC_E_403	10%	47%	0.272	0.806	1.1	0.94	2	2	0	0	81%	0.8095
6HZW_PLC_D_403	9%	11%	0.221	0.742	1.83	2.37	3	9	0	0	81%	0.8095
6HYW_PLC_D_401	8%	68%	0.272	0.783	0.48	0.74	-	1	0	0	81%	0.8095
4DOS_PLC_A_603	64%	52%	0.134	0.933	0.97	0.88	2	-	1	0	100%	0.869
4P00_PLC_A_922	12%	42%	0.283	0.836	1.12	1.12	2	3	1	0	90%	0.9048
4P02_PLC_B_802	10%	82%	0.251	0.892	0.26	0.54	-	-	0	0	26%	0.2619
5EJZ_PLC_B_803	10%	72%	0.261	0.91	0.3	0.77	-	-	1	0	21%	0.2143

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.